Drugs

Scientists are not routinely sloppy, clinicians don’t usually cheat, and clinical research is generally well designed. So why is it so hard to reproduce results?

An insider’s view of the effort to decode and model the entire immune system.

Maybe the science is finally catching up with BioViva CEO Elizabeth Parrish.

Our writer unpacks the data behind the new vaccines and wonders what happened to nuance in the CDC’s recommendations.

The ARDD meeting in Copenhagen this month featured new money, old experiments, endless enthusiasm, and a palpable sense of possibility.

The rise of biobanks around the world promised lots of cheap and plentiful human DNA for scientists to study. Here’s how that’s going.

Targeting a key molecule that helps the brain process sensory threats could lead to new treatments for PTSD, migraines, and autism.

Scientists have been scratching at the familiar, annoying phenomenon long enough now to produce a new crop of promising itch drugs.

A new study questions whether depression is really caused by a chemical imbalance.

On track to become a treatment for mental illnesses, growing research shows how psychedelics might also enhance creativity and concentration.